Arlette Emième

479 total citations
9 papers, 93 citations indexed

About

Arlette Emième is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Arlette Emième has authored 9 papers receiving a total of 93 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Arlette Emième's work include HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Arlette Emième is often cited by papers focused on HIV/AIDS Research and Interventions (6 papers), HIV Research and Treatment (4 papers) and HIV/AIDS drug development and treatment (4 papers). Arlette Emième collaborates with scholars based in Ivory Coast, France and United States. Arlette Emième's co-authors include Delphine Gabillard, Xavier Anglaret, Sarah Maylin, Anders Boyd, Christine Danel, Anani Badjé, Karine Lacombe, Raoul Moh, Éric Ouattara and Kévin Jean and has published in prestigious journals such as Clinical Infectious Diseases, AIDS and EBioMedicine.

In The Last Decade

Arlette Emième

9 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlette Emième Ivory Coast 6 63 57 40 29 6 9 93
Raffaele Dell’Acqua Italy 6 35 0.6× 46 0.8× 33 0.8× 26 0.9× 9 81
Reneta Dimitrova Bulgaria 6 39 0.6× 41 0.7× 23 0.6× 37 1.3× 23 75
M. Chirara Zimbabwe 6 60 1.0× 35 0.6× 50 1.3× 22 0.8× 7 85
Rozenn Esvan Italy 6 44 0.7× 46 0.8× 58 1.4× 5 0.2× 3 0.5× 16 110
Bao-Chau Phung France 5 62 1.0× 22 0.4× 42 1.1× 20 0.7× 6 76
Leon Claude Sidi Brazil 4 34 0.5× 36 0.6× 25 0.6× 16 0.6× 4 58
Tânia Reuter Brazil 7 58 0.9× 41 0.7× 35 0.9× 10 0.3× 19 94
Amalia Girón‐Callejas United States 7 28 0.4× 83 1.5× 13 0.3× 49 1.7× 17 85
Akaki Abutidze Georgia 7 147 2.3× 53 0.9× 112 2.8× 26 0.9× 28 176
Rafael Micán Spain 6 33 0.5× 49 0.9× 23 0.6× 35 1.2× 19 79

Countries citing papers authored by Arlette Emième

Since Specialization
Citations

This map shows the geographic impact of Arlette Emième's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlette Emième with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlette Emième more than expected).

Fields of papers citing papers by Arlette Emième

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlette Emième. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlette Emième. The network helps show where Arlette Emième may publish in the future.

Co-authorship network of co-authors of Arlette Emième

This figure shows the co-authorship network connecting the top 25 collaborators of Arlette Emième. A scholar is included among the top collaborators of Arlette Emième based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlette Emième. Arlette Emième is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kouamé, Gérard Menan, Delphine Gabillard, Raoul Moh, et al.. (2021). Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4+ cell counts. Antiviral Therapy. 26(1-2). 25–33. 4 indexed citations
2.
Gabillard, Delphine, Raoul Moh, Arlette Emième, et al.. (2020). Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts. EBioMedicine. 56. 102815–102815. 7 indexed citations
3.
Jean, Kévin, Delphine Gabillard, Raoul Moh, et al.. (2020). Association between Cellular HIV-1 DNA Level and Mortality in HIV-1 Infected African Adults Starting ART with High CD4 Counts. SSRN Electronic Journal. 2 indexed citations
4.
Mohareb, Amir M., Gérard Menan Kouamé, Audrey Gabassi, et al.. (2020). Mortality in relation to hepatitis B virus (HBV) infection status among HIV‐HBV co‐infected patients in sub‐Saharan Africa after immediate initiation of antiretroviral therapy. Journal of Viral Hepatitis. 28(4). 621–629. 5 indexed citations
5.
Boyd, Anders, Raoul Moh, Anani Badjé, et al.. (2017). Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication. Clinical Infectious Diseases. 66(1). 112–120. 45 indexed citations
6.
Amani‐Bosse, Clarisse, Désiré Lucien Dahourou, Karen Malateste, et al.. (2017). Virological response and resistances over 12 months among HIV‐infected children less than two years receiving first‐line lopinavir/ritonavir‐based antiretroviral therapy in Cote d’Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort. Journal of the International AIDS Society. 20(1). 21362–21362. 13 indexed citations
8.
Minga, Albert, Delphine Gabillard, Arlette Emième, et al.. (2011). CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters. AIDS. 25(6). 819–823. 9 indexed citations
9.
Minga, Albert, Arlette Emième, Roger Salamon, et al.. (2010). Short Communication: Severe Symptomatic Hyperlactatemia Among HIV Type 1-Infected Adults on Antiretroviral Therapy in Côte d'Ivoire. AIDS Research and Human Retroviruses. 26(9). 991–995. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026